ORIC PHARMACEUTICALS INC. - COMMON STOCK

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 12 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

09 11 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates

06 11 2023 15:10:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 11 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

02 11 2023 08:00:00 提供 Nasdaq GlobeNewswire

Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profile

21 10 2023 06:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023

17 10 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 10 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference

20 9 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 9 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

30 8 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates

10 8 2023 15:05:03 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04 8 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

26 6 2023 07:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 6 2023 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference

31 5 2023 15:10:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates

08 5 2023 15:05:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

05 5 2023 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference

25 4 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting

18 4 2023 15:15:00 提供 Nasdaq GlobeNewswire